Baylor Research Institute (BRI) is a dedicated research center for finding prevention therapies and treatments for diseases and illnesses. Our research is focused on the patient. This means our work involves more than microscopic studies - it brings the research to the patient's bedside. We work to understand the basis of a disease, identify potential treatments or preventive therapies, and enroll patients in research trials.

Established in 1984 and led by Michael Ramsay, MD, FRCA , BRI has a network of over 3000 board-certified physicians including approximately 500 active research investigators experienced in drug, device, and vaccine studies. In addition, BRI staffs approximately 250 employees, including scientists, laboratory assistants, and research coordinators. Serving more than 800,000 people at medical centers in Dallas, Fort Worth, Garland, Grapevine, Irving, Plano, Waxahachie, and Carrollton, Baylor Health Care System offers a large and diverse pool of potential research participants. Currently, more than 800 research projects are underway.

Baylor Research Institute collaborates with the medical industry to develop its technology and intellectual property. BRI is supported by philanthropy through the Baylor Health Care System Foundation and by grants from the National Institutes of Health and other national organizations. Baylor receives millions of dollars in research funding annually. The results of BRI's research--basic, applied, and clinical--are reported in major scientific publications and at national and international medical meetings.